Kaye I Foster-Cheek insider trades: Agios Pharmaceuticals (AGIO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kaye reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | AGIO | ↓ Sell | 1,285 | $31.62 | $41K | Direct | Mar 11, 2024 (4d) |
| Mar 6, 2024 | AGIO | ↓ Sell | 4,715 | $32.00 | $151K | Direct | Mar 7, 2024 (1d) |
| Aug 9, 2023 | AGIO | ↓ Sell | 25,000 | $25.96 | $649K | Direct | Aug 11, 2023 (2d) |
| Jun 14, 2018 | AGIO | ↓ Sell | 9,000 | $93.55 | $842K | Direct | Jun 18, 2018 (4d) |
| Mar 19, 2018 | AGIO | ↓ Sell | 6,800 | $81.97 | $557K | Direct | Mar 21, 2018 (2d) |
| Aug 6, 2013 | ONXX | ↓ Sell10b5-1 | 8,878 | $132.81 | $1.2M | Direct | Aug 8, 2013 (2d) |
| May 7, 2013 | ONXX | ↓ Sell10b5-1 | 8,877 | $89.84 | $797K | Direct | May 8, 2013 (1d) |
| Apr 2, 2013 | ONXX | ↓ Sell10b5-1 | 3,833 | $87.75 | $336K | Direct | Apr 3, 2013 (1d) |
| Feb 15, 2013 | ONXX | ↓ Sell10b5-1 | 16,164 | $74.96 | $1.2M | Direct | Feb 20, 2013 (5d) |
| Nov 6, 2012 | ONXX | ↓ Sell | 7,112 | $75.90 | $540K | Direct | Nov 8, 2012 (2d) |
| Oct 2, 2012 | ONXX | ↓ Sell | 2,015 | $85.08 | $171K | Direct | Oct 4, 2012 (2d) |
| Aug 6, 2012 | ONXX | ↓ Sell | 29,514 | $70.49 | $2.1M | Direct | Aug 8, 2012 (2d) |
| Jul 25, 2012 | ONXX | ↓ Sell | 2,335 | $73.97 | $173K | Direct | Jul 27, 2012 (2d) |
| Dec 5, 2011 | ONXX | ↓ Sell | 29,500 | $43.56 | $1.3M | Direct | Dec 7, 2011 (2d) |
| Oct 3, 2011 | ONXX | ↓ Sell10b5-1 | 1,605 | $29.75 | $48K | Direct | Oct 4, 2011 (1d) |
| Sep 23, 2011 | ONXX | ↓ Sell10b5-1 | 1,781 | $30.00 | $53K | Direct | Sep 26, 2011 (3d) |
| Dec 10, 2009 | JNJ | ↓ Sell | 96,742 | $64.76 | $6.3M | Direct | Dec 11, 2009 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AGIO insiders
Open-market trades in the last 12 months
About Kaye I Foster-Cheek's insider trades
Kaye I Foster-Cheek is a director at Agios Pharmaceuticals (AGIO). Since Dec 10, 2009, Kaye has reported no open-market purchases and 17 sales worth $16.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (22% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (35 filings), other transactions (22 filings), option exercises (20 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.